Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.
about
Location of superoxide anion generation in human colonic mucosa obtained by biopsy.Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitisProtective effects of Rheum tanguticum polysaccharide against hydrogen peroxide-induced intestinal epithelial cell injury.Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease.The neutrophil respiratory burst and bacterial digestion in Crohn's disease.Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.Environmental Enteric Dysfunction in Children.Resveratrol Pretreatment Ameliorates TNBS Colitis in Rats.Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.Biomarkers in the management of ulcerative colitis: a brief review.Tin protoporphyrin induces intestinal chloride secretion by inducing light oxidation processes.Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?Effect of enteral nutrition on antioxidant enzyme systems and inflammation in paediatric Crohn's disease.Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin.Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways.Treatment with Mesna and n-3 polyunsaturated fatty acids ameliorates experimental ulcerative colitis in rats.Protective role of uncoupling protein-2 against dextran sodium sulfate-induced colitis.
P2860
Q34376814-91DDD552-3536-452C-B402-5CDD57B23F1AQ34395621-5A80CF3F-B3C3-4D68-9ABE-2A5D36EAEDFEQ34945561-DC1D453C-9787-4B2A-819E-20307CCDDA8FQ35010443-A6A52DA5-A630-4CA1-97DC-F4AEDE19E9AEQ35350433-33A228BA-300A-4AFA-8166-65E2E06285A1Q36055798-26898235-FD45-4CAF-9088-57308BBA0DAEQ36816563-F48862E7-25CD-46B2-B4A8-5EA5AFEDFA8DQ37037319-C4B73A4A-DDEB-4151-812A-3CCEB243E774Q37204037-DD2C71EA-3860-4CF3-8A2A-20F32F920FF0Q37357109-B0133DAB-60DC-484B-8622-151A4D5B8902Q37851835-9E783141-90F1-4D5A-B16A-CAFB60C33B0FQ40184479-53847D19-5370-40DB-8DD1-4E23115F01FBQ40690714-5D39FDB3-7A13-4451-9C3C-3B52D0AB7384Q43724016-D49BBC98-5592-4695-A40B-4774634845C9Q45004853-B4722BE7-4A61-4EB9-960B-1C638BF0324CQ52639338-FC155D05-5D6F-44C6-B5A8-D2D8DAF025E5Q53181896-1EA2E6E9-B1A6-4242-B666-906D5386F742Q53223431-B870DD7C-620B-4BCE-B2D3-8547BD0756A0
P2860
Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Toxic oxygen metabolite produc ...... in inflammatory bowel disease.
@en
Toxic oxygen metabolite produc ...... in inflammatory bowel disease.
@nl
type
label
Toxic oxygen metabolite produc ...... in inflammatory bowel disease.
@en
Toxic oxygen metabolite produc ...... in inflammatory bowel disease.
@nl
prefLabel
Toxic oxygen metabolite produc ...... in inflammatory bowel disease.
@en
Toxic oxygen metabolite produc ...... in inflammatory bowel disease.
@nl
P2860
P356
P1433
P1476
Toxic oxygen metabolite produc ...... in inflammatory bowel disease.
@en
P2093
J G Williams
L E Hughes
P2860
P304
P356
10.1136/GUT.31.2.187
P407
P577
1990-02-01T00:00:00Z